Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.646924
Title: Novel O-glycan arrays to characterize human cancer-associated epithelial antigens
Author: Gao, Chao
ISNI:       0000 0004 5363 7822
Awarding Body: Imperial College London
Current Institution: Imperial College London
Date of Award: 2015
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Aberrantly expressed carbohydrates occur on cancer cells and are antigenic. This thesis is focused on studies to elucidate two elusive hybridoma-defined, cancer-associated carbohydrate antigens: a prostate cancer-associated antigen F77 and a broadly distributed epithelial cancer-associated antigen AE3. The key experiments performed are microarray analyses with mucin-type glycoproteins and generation of designer arrays, multidimensional chromatographies and mass spectrometry of O-glycomes. Antigen-positive sequences assigned are corroborated with focused arrays of natural and chemically synthetized oligosaccharides or glycolipids and products of glycosidase treatments. The F77 antigen is assigned as blood group H type 2 on a 6-linked branch of a poly-N-acetyllactosamine backbone (structure a). This sequence is shown to occur on O-glycans and on glycolipids. The F77 antibody can bind, with lower intensities, to the blood group A and B analogues of structure a. The minimum F77 antigenic sequence is shown to be a pentasaccharide (underlined in structure a). The close association of F77 antigen with prostate cancer is proposed to be a consequence of up-regulation of branching enzymes together with persistent expression of H antigen. This may account for the prevalence of F77 antigen in prostate cancers irrespective of the patient's ABO blood group status. There appear to be two distinct forms of AE3 antigen as evidenced by the ability of AE3 antibody to bind: (i) the O-glycan structure b, known as T antigen, which is joined by α-linkage to serine on mucin-type glycoproteins, and (ii) a sulphated glycolipid known as SM1a (structure c) in which 'T' sequence is joined by β-linkage to galactose. An O-glycan analogue of structure c (structure d), has not been reported so far. Chemo-enzymatic synthesis of structure d will shortly be attempted for antigenic analysis. With knowledge of details of these two antigens, the biosynthetic pathways, the biological functions and clinical applications can now be rationally pursued.
Supervisor: Feizi, Ten Sponsor: Wellcome Trust (London ; England)
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.646924  DOI: Not available
Share: